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Letter to the Editor
Strong evidence for multiple psychosis
susceptibility genes – a rejoinder to Crow
There are many mis-representations of our position
in Dr Crow’s response (Crow, 2008) to our comment
on his paper, but given recent empirical developments
in genetic research (Maher et al. 2008), there is little
need, and even less time, to engage in a protracted
debate on whether there is a genetic basis to psychosis.
In the last 2 months, a synthesis of genome-wide data
and large sample sets has convincingly shown that
common genetic variants, each of weak eﬀect, are in-
deed involved in schizophrenia (O’Donovan et al.
2008) and bipolar disorder (Ferreria et al. 2008).
Moreover, in schizophrenia, there is now consistent
and compelling evidence (The International Schizo-
phrenia Consortium, 2008; Stefansson et al. 2008) from
molecular genetics for a contribution to risk from copy
number variation (CNV), variants that result in the
deletion or duplication of 1000 bases or more of DNA
sequence. Read with an open mind, these recent
papers should change Dr Crow’s views.
While we make no argument that epigenetic
changes are not involved at all, the molecular data
clearly show genetic variation is involved. Moreover,
the molecular data clearly point to the involvement
in psychosis of multiple regions of the genome, not
some single sex-linked part of the genome involved
in language and speciation as Dr Crow has long pro-
posed. It must surely now be the time for Dr Crow
to reject his own hypothesis of a single cause of psy-
chosis, and to use his well-earned reputation in what-
ever way he can to enhance the ability of geneticists,
and epigeneticists (who are often the same people),
to get on with the job of tackling the complexities of
psychosis for the beneﬁts of our patients.
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